IBM Launches Cancer Analytics Platform

IBM launched an analytics platform that offers personalized treatments for a wide range of long-term health issues including cancer, hypertension and AIDS. The biomedical platform, named Clinical Genomics, was developed by IBM researchers in Haifa, Israel and combines personal health history with an analysis of guidelines and similar cases. The platform will deliver treatment recommendations based on an automated interpretation of pathology guidelines, as well as cases documented in hospital information systems. View and share